These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 9429020)
1. Growth hormone use by body builders. Davies JS; Morgan CL; Currie CJ; Green JT Br J Sports Med; 1997 Dec; 31(4):352-3. PubMed ID: 9429020 [No Abstract] [Full Text] [Related]
5. Creutzfeldt-Jakob disease in children treated with growth hormone. Billette de Villemeur TB; Beauvais P; Gourmelen M; Richardet JM Lancet; 1991 Apr; 337(8745):864-5. PubMed ID: 1672962 [No Abstract] [Full Text] [Related]
6. The human growth hormone Creutzfeld Jakob disease litigation. Owen R Med Leg J; 1997; 65 ( Pt 2)():46-64. PubMed ID: 9241994 [No Abstract] [Full Text] [Related]
7. Iatrogenic Creutzfeldt-Jakob disease presenting 24 years after human growth hormone administration. Hirst C Br J Hosp Med (Lond); 2005 Oct; 66(10):592-3. PubMed ID: 16255271 [No Abstract] [Full Text] [Related]
8. [Creutzfeldt-Jakob disease after treatment with growth hormone: the point in July, 1998]. Brandel JP; Agid Y Rev Neurol (Paris); 1998 Oct; 154(10):654-5. PubMed ID: 9846335 [No Abstract] [Full Text] [Related]
9. [Treatment with extractive growth hormone and Creutzfeld-Jakob encephalopathy: a new iatrogenic tragedy]. Battin J Pediatrie; 1993; 48(2):91-5. PubMed ID: 8393184 [No Abstract] [Full Text] [Related]
10. Preparation of growth hormone free from contamination with unconventional slow viruses. Taylor DM; Dickinson AG; Fraser H; Robertson PA; Salacinski PR; Lowry PJ Lancet; 1985 Aug; 2(8449):260-2. PubMed ID: 2862429 [No Abstract] [Full Text] [Related]
12. Iatrogenic Creutzfeldt-Jakob disease from commercial cadaveric human growth hormone. Appleby BS; Lu M; Bizzi A; Phillips MD; Berri SM; Harbison MD; Schonberger LB Emerg Infect Dis; 2013 Apr; 19(4):682-4. PubMed ID: 23750511 [No Abstract] [Full Text] [Related]
13. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease--being aware of diagnostic features 25 years later. Dixit K; Kreitschmann-Andermahr I; Basu A; Dick JP; Manoharan P; Shalet S; Brabant G J Clin Endocrinol Metab; 2009 Aug; 94(8):2684-5. PubMed ID: 19657045 [No Abstract] [Full Text] [Related]
14. Fatal degenerative neurologic disease in patients who received pituitary-derived human growth hormone. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(24):359-60, 365-6. PubMed ID: 3923319 [No Abstract] [Full Text] [Related]
15. [Iatrogenic Creutzfeld-Jakob disease induced by the administration of extracted growth hormone]. Rev Neurol (Paris); 1993; 149(10):515-6. PubMed ID: 8023062 [No Abstract] [Full Text] [Related]
16. Leads from the MMWR. Fatal degenerative neurologic disease in patients who received pituitary-derived human growth hormone. JAMA; 1985 Jul; 254(4):475, 479. PubMed ID: 3892063 [No Abstract] [Full Text] [Related]
17. Risk of Creutzfeldt-Jakob disease in bodybuilders. Perry HM BMJ; 1993 Sep; 307(6907):803. PubMed ID: 8219971 [No Abstract] [Full Text] [Related]
18. [Treatment of children with short stature with human growth hormone and its potential risks]. Sizonenko PC Arch Fr Pediatr; 1993 May; 50(5):369-74. PubMed ID: 8239885 [No Abstract] [Full Text] [Related]